In GBM, silencing of LRP1 was associated with a decreased level of phosphorylated ERK‐1/2 and increased levels of phosphorylated JNK‐1/2/3 [22], suggesting a potential pivotal role of LRP1 in regulating intracellular signal transduction involved in cancer progression. The gene discussed is MAPK3; the disease is glioblastoma.